Propranolol as a potentially novel treatment of arteriovenous malformations: from bench to bedside

• S. Kashefiolasl,
• M. Leisegang,
• R. Patel,
• P. Kan,
• C. Foerch,
• R. Du Mesnil,
• V. Seifert,
• R. Brandes,
• V. Prinz,
• J. Konczalla,
• J.-K. Burkhardt,
• M. Czabanka

Affiliations

S. Kashefiolasl

University Hospital Frankfurt, Neurosurgery, Frankfurt am Main, Germany

M. Leisegang

Goethe-University, Institute for Cardiovascular Physiology, Frankfurt am Main, Germany

R. Patel

Baylor College of Medicine, Department of Neurosurgery, Houston, United States

P. Kan

Baylor College of Medicine, Department of Neurosurgery, Houston, Germany

C. Foerch

University Hospital Frankfurt, Neurology, Frankfurt am Main, Germany

R. Du Mesnil

University Hospital Frankfurt, Institute of Neuroradiology, Frankfurt am Main, Germany

V. Seifert

University Hospital Frankfurt, Neurosurgery, Frankfurt am Main, Germany

R. Brandes

Goethe-University, Institute for Cardiovascular Physiology, Frankfurt am Main, Germany

V. Prinz

University Hospital Frankfurt, Neurosurgery, Frankfurt am Main, Germany

J. Konczalla

University Hospital Frankfurt, Neurosurgery, Frankfurt am MAin, Germany

J.-K. Burkhardt

Baylor College of Medicine, Department of Neurosurgery, Houston, Germany

M. Czabanka

University Hospital Frankfurt, Neurosurgery, Frankfurt am Main, Germany